See the DrugPatentWatch profile for vascepa

Based on the information provided, I conducted a search to find any current Vascepa promotions. Vascepa (icosapent ethyl) is a prescription medication used to lower triglyceride levels in adult patients. Here's what I found:

There is currently an ongoing Vascepa Savings Program available for eligible patients. This program allows eligible patients to save on their Vascepa prescriptions, with a maximum savings of up to $120 per prescription fill. The program is subject to eligibility requirements and terms and conditions. More information about the Vascepa Savings Program can be found on the official Vascepa website.

Additionally, I found a related article on DrugPatentWatch.com that discusses the patent expiration for Vascepa. According to the article, the patent for Vascepa expired in December 2020, which may lead to the introduction of generic versions of the drug in the future. However, the article does not mention any current promotions or savings programs for Vascepa.

In summary, based on the available information, there is a Vascepa Savings Program currently available for eligible patients, which allows them to save on their Vascepa prescriptions. Additionally, the patent for Vascepa expired in December 2020, which may lead to the introduction of generic versions of the drug in the future.

Sources:

1. Vascepa Savings Program. (n.d.). Vascepa. Retrieved March 22, 2023, from <https://www.vascepa.com/savings-program>.
2. DrugPatentWatch. (2021, January 21). Vascepa (icosapent ethyl) Patent Expiration & Generics. DrugPatentWatch. Retrieved March 22, 2023, from <https://www.drugpatentwatch.com/vascepa-patent>.